The studies of the biochemical changes in heart failure are as interesting and important as those in the field of haemodynamics. The metabolic changes are not only the results of disturbed metabolism in circulatory or cardiac failure but in themselves may become influencing factors in failure.
Among the products of metabolism, pyruvic acid is of great importance because it is an intermediary in carbohydrate, as well as in protein and in fat metabolism. Since newer methods for its estimation have been introduced by Lu (1939) and by Friedemann and Haugen (1943) , several authors have studied the role of pyruvic acid in heart diseases (Altschule and Rosenfeld, 1947; Barenghi, Scarlotti, and Scafidi, 1941; Lasch, 1952; Torre, Teece, and Baldantoni, 1950; Yanof, 1942) , and a survey of the changes in pyruvic acid levels in other diseases and in relation to therapy has been published by Markees (1951a) .
The purpose of this investigation was to study the level of blood pyruvic acid in patients with congestive heart failure and to ascertain: (1) whether the degree of severity of failure was reflected in changes of blood pyruvic acid values; (2) whether any relationship existed between liver size, liver function, and blood pyruvic acid; (3) whether therapy would influence the blood pyruvic acid level.
Clinical Data Ten healthy subjects fasting and at rest were chosen to obtain normal values of blood pyruvic acid. Forty patients, 20 men and 20 women, in various stages of congestive heart failure were also selected. The cardiac cases, classified according to aetiology, had arteriosclerotic or hypertensive cardiac and vascular diseases (20 cases); rheumatic heart disease (15 cases); chronic cor pulmonale (five cases Fig. 1 and Table  I ). Such hyperpyruvicaemia during acute episodes was found even in patients with mild failure (see Fig. 2) . The pyruvic acid level showed a tendency to drop with clinical improvement, and to rise with the increase of the failure (see Table I ). Case 28 (Fig. 2). -B. S., a man aged 46, had hypertensive cardiovascular disease, an old myocardial infarction, and residual hemianopia following a recent cerebral event. He was in mild heart failure.
The blood pressure was usually 180-200/100-110 mm. Hg.
He was admitted to hospital on January 1, 1952, in a state of unconsciousness which had developed suddenly after a rise in blood pressure to 225/150 mm. Hg. He recovered consciousness within a few hours of admission. He was exhausted and vomiting, but no pathological change was seen in the neurological or other clinical findings other than the old hemianopia. Next morning the patient had a high fasting blood pyruvic acid level, and the blood sugar level was elevated with transient glycosuria. Liver tests were negative. Rapid clinical improvement on the first day was maintained during the following days, the pyruvic acid and sugar dropping to normal; the blood pressure was moderately raised. On January 16 he was again " feeling bad," and the blood pressure and blood pyruvic acid and sugar levels had all risen. No change in the degree of heart failure was discernible. Within one more day recovery was complete.
Discussion
Technique.-The hydrazin method of Lu and of Friedemann-Haugen has been challenged by several authors (Elgart and Nelson, 1941 ; Klein, 1941 ;  Lestradet and Guest, 1951) , as it is an estimation of keto-acids in general and not only of pyruvic acid. Markees (1951b) has shown that boiling the filtrate for five minutes destroys the aceto-acetic acid (the main competitor of pyruvic acid) without loss of pyruvic acid.
Normal Values.-The normal values for blood pyruvic acid in healthy persons obtained in this study (0.53-1.08 mg. %) are in conformity with other reports irrespective of the methods used (Bueding, Wortis, and Stern, 1942; Friedemann and Haugen, 1943; Lu, 1939;  Markees, Kaser, and Lanz, 1950) .
Relation between Degree of Failure and Pyruvic Acid Level.- Fig. 1 (Davis and Bauer, 1944; Marche and Marnay, 1946; Amatuzio and Nesbitt, 1950; Kleeberg and Gitelson, 1953) because the damaged organ cannot metabolize this acid. On the other hand, severe heart failure is not infrequently associated with liver damage as a result of prolonged stasis and anoxia (Lichtman, 1949) . It is therefore conceivable that liver insufficiency may be responsible, at least partly, for the rise in pyruvic acid level in severe heart failure (Amatuzio and Nesbitt, 1950) .
In several of the severely ill patients a marked rise in pyruvic acid level coincided with deterioration in liver function (not indicated in Table I ). However, in general there was no close correlation between the changes in pyruvic acid level and in the results of the liver tests employed. This may be partly explained by the fact that these tests do not represent all facets of the manifold functions of the liver (King, 1952; Popper, 1952; Staub, 1950 In 13 patients an additional therapeutic trial was made with a phosphorylated thiaminchloride (cocarboxylase) intravenously. * Williams, Egana, Robinson, Asper, and Dutoit (1942) reported that intravenous injection of di-phospho-thiamine suppressed the high pyruvic acid level in thyrotoxic patients. In a series of animal experiments, as well as in clinical studies on diabetics and on pregnant women, Markees has urged the therapeutic use of co-carboxylase. His results (Markees and Meyer, 1949) were remarkable in alloxan-diabetic rabbits as well as in human beings with severe diabetes. The effect was especially striking in regulating acidosis.
Using this method, Torre et al. (1950) (Ochoa, 1939 ; Torre et al., 1950; Yanof, 1942) .
It is well known that anoxia increases the breakdown of glycogen and decreases the oxidation of its split-products, pyruvic acid and lactic acid, in the liver. This leads to a rise in the concentration of these products, as well as of glucose, in the blood.
Actually several of the patients with severe heart failure or myocardial infarction had simultaneously high blood 
